Overview of the Latest SEER Data and the Impact of COVID on Cancer Incidence Trends and Reporting
If you’re interested in how COVID-19 and how the stay-at-home orders impacted cancer diagnosis, make sure you register for this webinar.
You can use SEER*Explorer to access a wide range of cancer statistics and data. During this webinar, you’ll hear from NCI Division of Cancer Control and Population Sciences (DCCPS) experts on how this data can help us understand COVID-19’s impact on cancer diagnosis.
Drs. Nadia Howlader, Angela Mariotto, and Annie Noone will discuss:
- challenges in reporting cancer cases and trends in 2020.
- examples of the impact of the 2020 data point.
- monthly trends in cancer diagnoses before and after the stay-at-home orders.
Dr. Howlader is a statistician and epidemiologist in the Surveillance Research Program in DCCPS. Her research focuses on breast cancer, non-Hodgkin lymphoma, and lung cancer occurrences and outcomes. Her work at NCI involves applying analytic tools using diverse data systems.
Dr. Mariotto is a statistician and chief of the Data Analytics Branch in DCCPS. Her research interests include development and improvement of cancer progress measures, (i.e., survival, prevalence, quality of life, utilization, and cost measures).
Dr. Noone is a statistician and epidemiologist in the Surveillance Research Program in DCCPS. Her research focuses on applying statistical methods to surveillance data in novel ways. This includes utilizing a variety of data sources such as registry data, Medicare claims, and national mortality data.
Upcoming Events
- Molecular Characterization Initiative (MCI) Update: Pediatric Soft Tissue SarcomasDecember 10, 2024AI-Foundational Models for Cancer Imaging BiomarkersDecember 17, 2024NCI Symposium on Translational Technologies for Global HealthMarch 19, 2025 - March 20, 2025